Keel Point »

Gt Biopharma shares owned by Keel Point

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Keel Point from 13F filings

Historical chart of Keel Point investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Keel Point consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Keel Point

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.5k 21k 0.41

More positions owned by Keel Point

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Netflix (NFLX)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Rus 1000 Etf (IWB)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Eafe Etf (EFA)
Apple (AAPL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Amazon (AMZN)
Tesla Motors (TSLA)
Ishares Tr Rus 1000 Grw Etf (IWF)

View all positions for Keel Point

Top funds holding Gt Biopharma

Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
SRS Capital Advisors
Citadel Advisors
SeaCrest Wealth Management
UBS Group
Two Sigma Securities
LPL Financial
Invst
Keel Point
HPM Partners
Integrated Wealth Concepts
Private Wealth Management Group
Coston, McIsaac & Partners

View all funds holding Gt Biopharma